Candel Therapeutics Statistics

Total Valuation

CADL has a market cap or net worth of $292.61 million. The enterprise value is $212.85 million.

Market Cap	292.61M
Enterprise Value	212.85M

Important Dates

The last earnings date was Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

CADL has 54.90 million shares outstanding. The number of shares has increased by 60.30% in one year.

Current Share Class	54.90M
Shares Outstanding	54.90M
Shares Change (YoY)	+60.30%
Shares Change (QoQ)	+6.61%
Owned by Insiders (%)	9.71%
Owned by Institutions (%)	43.81%
Float	45.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.65
P/TBV Ratio	3.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.25, with a Debt / Equity ratio of 0.09.

Current Ratio	8.25
Quick Ratio	7.96
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-36.44

Financial Efficiency

Return on equity (ROE) is -70.17% and return on invested capital (ROIC) is -56.52%.

Return on Equity (ROE)	-70.17%
Return on Assets (ROA)	-43.25%
Return on Invested Capital (ROIC)	-56.52%
Return on Capital Employed (ROCE)	-48.18%
Revenue Per Employee	n/a
Profits Per Employee	-$598,921
Employee Count	38
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.32% in the last 52 weeks. The beta is -0.92, so CADL's price volatility has been lower than the market average.

Beta (5Y)	-0.92
52-Week Price Change	+20.32%
50-Day Moving Average	5.23
200-Day Moving Average	5.79
Relative Strength Index (RSI)	59.76
Average Volume (20 Days)	766,256

Short Selling Information

The latest short interest is 8.34 million, so 15.20% of the outstanding shares have been sold short.

Short Interest	8.34M
Short Previous Month	7.48M
Short % of Shares Out	15.20%
Short % of Float	18.35%
Short Ratio (days to cover)	11.24

Income Statement

Revenue	n/a
Gross Profit	-23.07M
Operating Income	-39.83M
Pretax Income	-22.76M
Net Income	-22.76M
EBITDA	-38.90M
EBIT	-39.83M
Earnings Per Share (EPS)	-$0.47

Full Income Statement

Balance Sheet

The company has $86.96 million in cash and $7.21 million in debt, giving a net cash position of $79.76 million or $1.45 per share.

Cash & Cash Equivalents	86.96M
Total Debt	7.21M
Net Cash	79.76M
Net Cash Per Share	$1.45
Equity (Book Value)	80.12M
Book Value Per Share	1.46
Working Capital	79.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$33.56 million and capital expenditures -$181,000, giving a free cash flow of -$33.74 million.

Operating Cash Flow	-33.56M
Capital Expenditures	-181,000
Free Cash Flow	-33.74M
FCF Per Share	-$0.61

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CADL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-60.30%
Shareholder Yield	-60.30%
Earnings Yield	-7.78%
FCF Yield	-11.53%

Analyst Forecast

The average price target for CADL is $19.43, which is 264.54% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.43
Price Target Difference	264.54%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2